NCT04680052 2025-12-22InMINDIncyte CorporationPhase 3 Active not recruiting654 enrolled 40 charts 1 FDA
NCT05788289 2025-05-25A Study of Tafasitamab and Lenalidomide in People With Mantle Cell LymphomaMemorial Sloan Kettering Cancer CenterPhase 2 Terminated4 enrolled 8 charts